Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

Overexpression of epidermal growth factor receptors (EGFR) occurs in >90% of pancreatic ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic review of electronic databases identified studies exploring the addition of EGFR-targeted treatment to chemotherapy in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiramel, Jaseela, Backen, Alison C., Pihlak, Rille, Lamarca, Angela, Frizziero, Melissa, Tariq, Noor-ul-Ain, Hubner, Richard A., Valle, Juan W., Amir, Eitan, McNamara, Mairéad G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454822/
https://www.ncbi.nlm.nih.gov/pubmed/28445400
http://dx.doi.org/10.3390/ijms18050909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454822/
https://www.ncbi.nlm.nih.gov/pubmed/28445400
http://dx.doi.org/10.3390/ijms18050909

Ejemplares similares